Fosun International LTD Theravance Biopharma, Inc. Transaction History

Fosun International LTD

  • $106 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$16.51 - $23.78 $3.07 Million - $4.42 Million
-185,899 Closed
0 $0
Q2 2019

Aug 12, 2019
BUY
$15.6 - $25.15 $1.27 Million - $2.05 Million
81,434 Added 77.95%
185,899 $2.97 Million
Q1 2019

May 10, 2019
BUY
$22.57 - $28.15 $2.36 Million - $2.94 Million
104,465 New
104,465 $2.39 Million

Others Institutions Holding TBPH

# of Institutions
122
Shares Held
47.3M
Call Options Held
200
Put Options Held
12.8K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $654M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email